EBT-103

N/A

Report date: 2025/08/20 16:52:42

Base Information

Drug NameEBT-103
Drug Alias NameEBT-103
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukoencephalopathy, Progressive Multifocal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLeukoencephalopathy, Progressive Multifocal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A